Clinical characteristics and treatment outcomes in patients with liver cirrhosis and lymphoma

Table 3 Characteristics of the lymphoma cases, n (%)

Characteristics of lymphomas	Cases (n = 10)	Controls (n = 20)
Lymphoma type and subtypes
Non-Hodgkin lymphoma	9 (90)	18 (90)
Diffuse large B cell	7 (70)	17 (85)
Follicular	1 (10)	0 (0)
Others	1 (10)	1 (5)
Hodgkin lymphoma	1 (10)	2 (10)
Nodular sclerosis	0 (0)	1 (5)
Lymphocyte predominant	0 (0)	1 (5)
Lymphocyte depleted	1 (10)	0 (0)
Clinical stages
I	1 (10)	4 (20)
II	2 (20)	3 (15)
III	1 (10)	6 (30)
IV	6 (60)	7 (35)
Extra nodal involvement	6 (60)	9 (45)
Prognostic scale
IPI score	3 (2.5-3)a	2 (1-3)
FLIPI score	3	-
IPS score	3	2.5
ECOG Performance Status	2 (1-2.25)	2 (1-2)
B symptoms
Fever	3 (30)	6 (30)
Weight loss	9 (90)	11 (55)
Nocturnal diaphoresis	4 (40)	6 (30)
Helicobacter pylori	3 (30)a	0 (0)

Median (p25-p75), absolute frequencies (%);

^aP < 0.05 vs controls; ^bP < 0.01 vs controls. IPI: International Prognostic Index; FLIPI: Follicular Lymphoma International Prognostic Index; IPS: International Prognostic Score; ECOG: Eastern Cooperative Oncology Group scale of Performance Status.